Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPG 7909 + Radiation in Recurrent Mycosis Fungoides
NCT00226993Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Mar 2005
- Primary completion
- Dec 2006
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
01
Overview
A Phase 2 trial of agatolimod in mycosis fungoides (MF), sponsored by Stanford University. Planned start Mar 2005; status: withdrawn.
02
Drugs
agatolimod
03
Conditions
mycosis fungoides (MF)
Beyond the preview
Go deeper on NCT00226993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226993.